Lysosomal Protein Transmembrane 4 beta (LAPTM4B) (Middle Region) Peptid
Kurzübersicht für Lysosomal Protein Transmembrane 4 beta (LAPTM4B) (Middle Region) Peptid (ABIN8104700)
Target
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Verwendungszweck
- LAPTM4B Peptide - middle region
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-LAPTM4B antibody ( ARP47442_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- LAPTM4B (Lysosomal Protein Transmembrane 4 beta (LAPTM4B))
-
Hintergrund
-
Background Information: LAPTM4B is a multi-pass membrane protein. It belongs to the LAPTM4/LAPTM5 transporter family. LAPTM4b has active role in disease progression of malignant cells and is involved in cell proliferation and multidrug resistance. The genetic polymorphism of LAPTM4B is a potential risk factor for the development of colon cancer and gastric cancer. The research results also indicated that LAPTM4B may be a clinically useful prognostic indicator for ovarian carcinoma and may play a role in human hepatocellular carcinoma.
Alternative Symbols: LAPTM4beta, LC27
-
Molekulargewicht
- 35kDa
-
Gen-ID
- 55353
-
NCBI Accession
- NP_060877
-
UniProt
- Q86VI4
Target
-